Literature DB >> 1367634

Enhancing the thermostability of glucose isomerase by protein engineering.

W J Quax1, N T Mrabet, R G Luiten, P W Schuurhuizen, P Stanssens, I Lasters.   

Abstract

We have engineered recombinant glucose isomerase (GI) from Actinoplanes missouriensis by site-directed mutagenesis to enhance its thermal stability in both the soluble and immobilized forms. Substitution of arginine for lysine at position 253, which lies at the dimer/dimer interface of the GI tetramer, produced the largest stabilization under model industrial conditions. We discuss our results in terms of a model in which chemical glycation of lysines by sugars in the industrial corn syrup substrate represents a major pathway of destabilization.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1367634     DOI: 10.1038/nbt0891-738

Source DB:  PubMed          Journal:  Biotechnology (N Y)        ISSN: 0733-222X


  6 in total

Review 1.  Hyperthermophilic enzymes: sources, uses, and molecular mechanisms for thermostability.

Authors:  C Vieille; G J Zeikus
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

Review 2.  Molecular and industrial aspects of glucose isomerase.

Authors:  S H Bhosale; M B Rao; V V Deshpande
Journal:  Microbiol Rev       Date:  1996-06

3.  xylA cloning and sequencing and biochemical characterization of xylose isomerase from Thermotoga neapolitana.

Authors:  C Vieille; J M Hess; R M Kelly; J G Zeikus
Journal:  Appl Environ Microbiol       Date:  1995-05       Impact factor: 4.792

4.  Arthrobacter D-xylose isomerase: protein-engineered subunit interfaces.

Authors:  L Varsani; T Cui; M Rangarajan; B S Hartley; J Goldberg; C Collyer; D M Blow
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

5.  Enzymes in food processing: a condensed overview on strategies for better biocatalysts.

Authors:  Pedro Fernandes
Journal:  Enzyme Res       Date:  2010-09-29

6.  Development of a new Bacillus carboxyl esterase for use in the resolution of chiral drugs.

Authors:  W J Quax; C P Broekhuizen
Journal:  Appl Microbiol Biotechnol       Date:  1994-06       Impact factor: 4.813

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.